SMT201700056B - Fosfaplatine e relativo utilizzo per il trattamento di cancro - Google Patents

Fosfaplatine e relativo utilizzo per il trattamento di cancro

Info

Publication number: SMT201700056B
Authority: SM; San Marino
Prior art keywords: phosphaplatin; cancer treatment; related use; cancer; treatment
Prior art date: 2010-06-04

Application number

SM201700056T

Other languages

English (en)

Inventor

Rathindra N Bose

Original Assignee

Univ Ohio

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-06-04

Filing date

2017-01-25

Publication date

2017-03-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44627266&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201700056(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2017-01-25 Application filed by Univ Ohio filed Critical Univ Ohio

2017-03-08 Publication of SMT201700056B publication Critical patent/SMT201700056B/it

Links

206010028980 Neoplasm Diseases 0.000 title 1
201000011510 cancer Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SM201700056T 2010-06-04 2017-01-25 Fosfaplatine e relativo utilizzo per il trattamento di cancro SMT201700056B (it)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US35151410P	2010-06-04	2010-06-04
PCT/US2011/038948 WO2011153365A1 (en)	2010-06-04	2011-06-02	Phosphaplatins and their use for treatment of cancers

Publications (1)

Publication Number	Publication Date
SMT201700056B true SMT201700056B (it)	2017-03-08

Family

ID=44627266

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM201700056T SMT201700056B (it)	2010-06-04	2017-01-25	Fosfaplatine e relativo utilizzo per il trattamento di cancro

Country Status (30)

Country	Link
US (4)	US9688709B2 (it)
EP (1)	EP2575802B1 (it)
JP (1)	JP5860872B2 (it)
KR (1)	KR101775410B1 (it)
CN (6)	CN108392490A (it)
AP (1)	AP3480A (it)
AU (1)	AU2011261381B2 (it)
BR (1)	BR112012030927B1 (it)
CA (1)	CA2800898C (it)
CL (1)	CL2012003416A1 (it)
CO (1)	CO6640302A2 (it)
CY (1)	CY1118466T1 (it)
DK (1)	DK2575802T3 (it)
EA (1)	EA021526B1 (it)
ES (1)	ES2606855T3 (it)
HR (1)	HRP20170225T1 (it)
HU (1)	HUE030249T2 (it)
IL (1)	IL223405B (it)
LT (1)	LT2575802T (it)
MX (1)	MX2012014174A (it)
MY (1)	MY162902A (it)
NZ (1)	NZ603952A (it)
PL (1)	PL2575802T3 (it)
PT (1)	PT2575802T (it)
RS (1)	RS55714B1 (it)
SG (1)	SG185722A1 (it)
SI (1)	SI2575802T1 (it)
SM (1)	SMT201700056B (it)
WO (1)	WO2011153365A1 (it)
ZA (1)	ZA201209007B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5860872B2 (ja)	2010-06-04	2016-02-16	オハイオユニバーシティー	ホスファプラチン、及び癌治療のためのそれらの使用
CA2818933A1 (en) *	2011-01-12	2012-07-19	Ohio University	Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof
CN104010508B (zh) *	2011-10-05	2017-03-15	理辛德拉·N·博斯	用于大规模制备磷铂类抗肿瘤剂的高效方法
US9012669B2 (en)	2011-10-05	2015-04-21	The University Of Houston System	Efficient processes for large scale preparation of phosphaplatins antitumor agents
PT2855496T (pt) *	2012-05-24	2017-03-23	Phosplatin Therapeutics Llc	Processos de síntese e de purificação para compostos de fosfaplatina e aplicações dos mesmos
WO2014130776A1 (en)	2013-02-22	2014-08-28	University Of Houston	Phosphaplatins as neuroprotective agents
WO2015127037A1 (en) *	2014-02-19	2015-08-27	University Of Houston System	Compositions and methods for the treatment of neurodegenerative diseases
BR112018070603A2 (pt) *	2016-04-06	2019-02-05	Phosplatin Therapeutics Llc	formulações líquidas de fosfaplatina
JP7023968B2 (ja) *	2017-01-06	2022-02-22	フォスプラティン・セラピューティクス・インコーポレーテッド	骨がんまたは血液がんの治療のための治療薬としてのホスファプラチン化合物
WO2019051246A1 (en) *	2017-09-08	2019-03-14	Phosplatin Therapeutics Llc	PHOSPHAPLATINE COMPOUNDS AS IMMUNOMODULATORS AND THERAPEUTIC USES THEREOF
WO2022087173A1 (en) *	2020-10-20	2022-04-28	Phosplatin Therapeutics Inc.	Phosphaplatin compounds as therapeutic agents selectively targeting highly glycolytic tumor cells and methods thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4291027A (en)	1979-03-07	1981-09-22	Engelhard Minerals & Chemicals Corp.	Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
US4234500A (en)	1979-03-07	1980-11-18	Engelhard Minerals & Chemicals Corporation	Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
CA2017739A1 (en)	1989-07-18	1991-01-18	Leslie S. Hollis	Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents
AUPR330201A0 (en)	2001-02-23	2001-03-22	University Of Sydney, The	Metal complexes and therapeutic uses thereof
DE10314780A1 (de)	2003-03-19	2004-09-30	Ktb Tumorforschungsgesellschaft Mbh	Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden
WO2004098524A2 (en)	2003-05-02	2004-11-18	Aronex Pharmaceuticals, Inc.	Lipid platinum complexes and methods of use thereof
WO2005000858A2 (en)	2003-06-27	2005-01-06	Akira Odani	Bisphosphonate complexes
EP2177525A1 (en)	2007-07-06	2010-04-21	TMRC Co., Ltd.	Metal complex compound, cancer therapeutic composition comprising the metal complex compound as active ingredient, and intermediate for production of the metal complex compound
WO2009021081A2 (en)	2007-08-06	2009-02-12	Ohio University	Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
JP5553275B2 (ja)	2010-03-31	2014-07-16	国立大学法人金沢大学	金属錯体およびこれを有効成分として含有する抗がん剤
JP5860872B2 (ja)	2010-06-04	2016-02-16	オハイオユニバーシティー	ホスファプラチン、及び癌治療のためのそれらの使用
CA2818933A1 (en)	2011-01-12	2012-07-19	Ohio University	Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof
US9012669B2 (en) *	2011-10-05	2015-04-21	The University Of Houston System	Efficient processes for large scale preparation of phosphaplatins antitumor agents

2011
- 2011-06-02 JP JP2013513350A patent/JP5860872B2/ja active Active
- 2011-06-02 NZ NZ603952A patent/NZ603952A/en unknown
- 2011-06-02 WO PCT/US2011/038948 patent/WO2011153365A1/en active Application Filing
- 2011-06-02 CN CN201810150470.4A patent/CN108392490A/zh active Pending
- 2011-06-02 AP AP2012006594A patent/AP3480A/xx active
- 2011-06-02 ES ES11726567.8T patent/ES2606855T3/es active Active
- 2011-06-02 EP EP11726567.8A patent/EP2575802B1/en active Active
- 2011-06-02 PT PT117265678T patent/PT2575802T/pt unknown
- 2011-06-02 DK DK11726567.8T patent/DK2575802T3/en active
- 2011-06-02 HU HUE11726567A patent/HUE030249T2/en unknown
- 2011-06-02 CN CN2011800387165A patent/CN103037859A/zh active Pending
- 2011-06-02 US US13/701,313 patent/US9688709B2/en active Active
- 2011-06-02 CN CN201810150496.9A patent/CN108409795A/zh active Pending
- 2011-06-02 SG SG2012086229A patent/SG185722A1/en unknown
- 2011-06-02 CN CN201810150614.6A patent/CN108299508A/zh active Pending
- 2011-06-02 KR KR1020137000158A patent/KR101775410B1/ko not_active Application Discontinuation
- 2011-06-02 LT LTEP11726567.8T patent/LT2575802T/lt unknown
- 2011-06-02 MX MX2012014174A patent/MX2012014174A/es active IP Right Grant
- 2011-06-02 RS RS20170139A patent/RS55714B1/sr unknown
- 2011-06-02 EA EA201270812A patent/EA021526B1/ru unknown
- 2011-06-02 AU AU2011261381A patent/AU2011261381B2/en active Active
- 2011-06-02 CN CN201810150487.XA patent/CN108210516A/zh active Pending
- 2011-06-02 BR BR112012030927-7A patent/BR112012030927B1/pt active IP Right Grant
- 2011-06-02 SI SI201131103A patent/SI2575802T1/sl unknown
- 2011-06-02 CA CA2800898A patent/CA2800898C/en active Active
- 2011-06-02 PL PL11726567T patent/PL2575802T3/pl unknown
- 2011-06-02 MY MYPI2012005178A patent/MY162902A/en unknown
- 2011-06-02 CN CN201810150598.0A patent/CN108186651A/zh active Pending
2012
- 2012-11-28 ZA ZA2012/09007A patent/ZA201209007B/en unknown
- 2012-12-03 IL IL223405A patent/IL223405B/en active IP Right Grant
- 2012-12-04 CO CO12219958A patent/CO6640302A2/es not_active Application Discontinuation
- 2012-12-04 CL CL2012003416A patent/CL2012003416A1/es unknown
2016
- 2016-12-22 CY CY20161101332T patent/CY1118466T1/el unknown
2017
- 2017-01-25 SM SM201700056T patent/SMT201700056B/it unknown
- 2017-02-10 HR HRP20170225TT patent/HRP20170225T1/hr unknown
- 2017-05-24 US US15/604,237 patent/US10364264B2/en active Active
- 2017-05-24 US US15/604,209 patent/US10385083B2/en active Active
2019
- 2019-06-26 US US16/453,303 patent/US10759820B2/en active Active

Also Published As

Publication number	Publication date
AU2011261381A1 (en)	2013-01-10
CN108409795A (zh)	2018-08-17
CA2800898C (en)	2018-12-04
US20130064902A1 (en)	2013-03-14
EP2575802B1 (en)	2016-11-16
CN108210516A (zh)	2018-06-29
US20170327522A1 (en)	2017-11-16
SG185722A1 (en)	2013-01-30
EP2575802A1 (en)	2013-04-10
LT2575802T (lt)	2016-12-27
CA2800898A1 (en)	2011-12-08
RS55714B1 (sr)	2017-07-31
CO6640302A2 (es)	2013-03-22
BR112012030927A2 (pt)	2017-12-05
CN108186651A (zh)	2018-06-22
IL223405B (en)	2018-11-29
MY162902A (en)	2017-07-31
CY1118466T1 (el)	2017-07-12
ZA201209007B (en)	2013-08-28
MX2012014174A (es)	2013-07-03
PT2575802T (pt)	2016-12-27
DK2575802T3 (en)	2017-01-09
CN108392490A (zh)	2018-08-14
BR112012030927B1 (pt)	2021-09-21
CL2012003416A1 (es)	2013-09-06
KR20130095244A (ko)	2013-08-27
NZ603952A (en)	2014-07-25
WO2011153365A1 (en)	2011-12-08
HRP20170225T1 (hr)	2017-04-07
JP2013529219A (ja)	2013-07-18
US20190315789A1 (en)	2019-10-17
JP5860872B2 (ja)	2016-02-16
CN108299508A (zh)	2018-07-20
HUE030249T2 (en)	2017-04-28
EA201270812A1 (ru)	2013-05-30
US10385083B2 (en)	2019-08-20
CN103037859A (zh)	2013-04-10
AP2012006594A0 (en)	2012-12-31
US10364264B2 (en)	2019-07-30
ES2606855T3 (es)	2017-03-28
US10759820B2 (en)	2020-09-01
US9688709B2 (en)	2017-06-27
AU2011261381B2 (en)	2015-04-02
EA021526B1 (ru)	2015-07-30
AP3480A (en)	2015-12-31
KR101775410B1 (ko)	2017-09-06
SI2575802T1 (sl)	2017-03-31
US20170327521A1 (en)	2017-11-16
PL2575802T3 (pl)	2017-04-28

Publication	Publication Date	Title
SMT201700056B (it)	2017-03-08	Fosfaplatine e relativo utilizzo per il trattamento di cancro
SMT201600430B (it)	2017-01-10	Inibitori di chinasi e loro uso nel trattamento del cancro
SMT201600370B (it)	2016-11-10	Complessi chelati di oligonucleotidi
DK2707030T3 (da)	2020-05-18	Cancerbehandlinger
BR112012005594A2 (pt)	2015-09-08	tratamento de câncer
BR112012018947A2 (pt)	2017-06-27	composição farmacêutica para tratamento e\ou prevenção do cancêr
BR112014009755A2 (pt)	2017-04-25	tratamento de câncer com inibidores de quinase tor
ZA201207574B (en)	2014-09-25	Phytocannabinoids in the treatment of cancer
DE112011100715T8 (de)	2013-03-28	Hardware-hilfs-thread
ES2638522T8 (es)	2021-02-11	Procedimientos para detectar cáncer
IT1400425B1 (it)	2013-05-31	Modified snrnas for use in therapy.
BRPI1008566A2 (pt)	2017-06-06	métodos e composições para o diagnóstico e tratamento de câncer
SG10201508495VA (en)	2015-11-27	Combination treatment of cancer
BRPI1007972A2 (pt)	2016-09-13	composições de combinação e métodos para o tratamento de câncer
BR112014012880A2 (pt)	2017-06-13	tratamento imunogênico do câncer
BRPI1008564A2 (pt)	2018-02-27	métodos e composições para o dignóstico e tratamento de câncer
ITTO20110641A1 (it)	2012-01-16	Composizioni farmaceutiche e metodi di trattamento
BR112013011659A2 (pt)	2016-08-02	métodos de tratamento do câncer
BRPI1007995A2 (pt)	2019-09-24	orto-aminoamidas para o tratamento de cãncer.
IL222958A0 (en)	2013-02-03	Cancer treatment
EP2603222A4 (en)	2014-01-01	COMBINATIVE CANCER TREATMENT
DK2642992T3 (da)	2021-03-01	Forbindelser og anvendelse deraf
IT1398438B1 (it)	2013-02-22	Dispositivo di premacinazione e relativo procedimento
BR112013023452A2 (pt)	2016-12-06	combinação de oligonucleotídeo anti-clusterina com inibidor de hsp90 para o tratamento de câncer de próstata
BR112013028890A2 (pt)	2017-01-31	composições e métodos para o tratamento de câncer